KI-328 is a KIT kinase inhibitor with selective activity against certain KIT mutant kinases commonly found in acute myeloid leukemia (AML); it exhibits specificity for KIT kinase in in vitro kinase assays and inhibits the growth of both wild-type (WT) and mutant KIT-expressing cells, albeit with lower activity against D816V-KIT.